-
Mashup Score: 11Elevating health care for all - 2 day(s) ago
See how AbbVie goes beyond the numbers to increase representation in clinical trials.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Immunology’s Next Frontier - 5 day(s) ago
Twenty years ago, Tim Radstake, M.D., saw history in the making – the results of a new treatment for patients with rheumatoid arthritis (RA), a chronic, autoimmune disease. At the hospital where he worked at the time, the treatment was administered to one of its very first patients. Later, the patient’s husband came back, filled with emotion. “When we saw him, everyone feared something was wrong, but what actually happened was his wife was able to do something she hadn’t done in years – get out of
Source: www.abbvie.comCategories: General Medicine News, PayerTweet-
People living with autoimmune diseases often go through a trial-and-error process to find the right treatment. Our #scientists are making big bets in research to help match the right patients to the right therapies at the right time. Explore: https://t.co/kLmJhaiyv6 #WorldIBDDay https://t.co/sNhNS6MrTj
-
-
Mashup Score: 3Environmental, Social & Governance - 22 day(s) ago
We are advancing environmental, social and governance (ESG) initiatives that contribute to the sustainable growth of our company so that we can create positive impact for generations to come. Our ESG framework is built around three pillars that were developed based on our six core material drivers: product innovation, human capital management, product quality and safety, business ethics, patient health and engagement, and patient access and affordability.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7
See how the AbbVie-Calico Life Sciences collaboration turns the traditional partnership upside down to tackle age-related diseases.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 13Neuroscience - 1 month(s) ago
AbbVie scientists are focused on how to bring better solutions and therapies to people living with neurological and psychiatric disorders.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 14The Case for Big Bets - 2 month(s) ago
Because thinking small never changed the world.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12A Legacy Of Leadership In Mental Health - 2 month(s) ago
Leveraging years of research and development, AbbVIe scientists are committed to finding answers to some of the most complex questions in psychiatry.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 3Not good enough: behind the drive to give cancer patients more time - 3 month(s) ago
Two R&D leaders discuss AbbVie’s approach to develop solid tumor treatments.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Immunology’s Next Frontier - 3 month(s) ago
Twenty years ago, Tim Radstake, M.D., saw history in the making – the results of a new treatment for patients with rheumatoid arthritis (RA), a chronic, autoimmune disease. At the hospital where he worked at the time, the treatment was administered to one of its very first patients. Later, the patient’s husband came back, filled with emotion. “When we saw him, everyone feared something was wrong, but what actually happened was his wife was able to do something she hadn’t done in years – get out of
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7Immunology - 3 month(s) ago
AbbVie develops innovative medicines and therapies so patients can live more fully. Learn more about our immunology research to address chronic diseases.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
Making #ClinicalTrials work better for all people takes work from all of us. We’re doing our part by taking bold steps to drive greater representation. See how this work engages patients, caregivers and doctors to drive lasting change. https://t.co/Ct6d2ZeH78 https://t.co/l9pGNlzKuS